Home › Funds › Bleichroeder LP › KZIA
Bleichroeder LP position in KZIA
KAZIA THERAPEUTICS · Health Care
Bleichroeder LP reported holding 490,410 shares of KZIA (KAZIA THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.47% of its reported portfolio and ranking #46 among its reported holdings. Bleichroeder LP has disclosed KZIA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Bleichroeder LP's KZIA position evolved
Bleichroeder LP first disclosed a stake in KZIA in Q4 2025 at 400,000 shares (US$2.8M). The position peaked in Q2 2026 at 400,000 shares, worth US$5.6M. Across 4 filings, Bleichroeder LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 490,410 shares valued at US$4.7M — an increase of 90,410 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 400.00K | $2.76M | New |
| Q1 2026 | 400.00K | $2.98M | Hold |
| Q2 2026 | 400.00K | $5.63M | Hold |
| Q3 2026 | 490.41K | $4.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KZIA and 13F data
KZIA (KAZIA THERAPEUTICS) is a Health Care company. 50 other funds we track also report a position in KZIA — the largest reported positions include Boxer Capital Management, LLC (US$7.9M), Ikarian Capital, LLC (US$5.6M), Dauntless Investment Group, LLC (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KZIA
- Boxer Capital Management, LLC 560.00K sh · $7.88M · Q2 2026
- Ikarian Capital, LLC 396.20K sh · $5.58M · Q2 2026
- Dauntless Investment Group, LLC 354.21K sh · $4.99M · Q2 2026
- Stonepine Capital Management, LLC 345.18K sh · $4.86M · Q2 2026
- COOPERMAN LEON G 50.00K sh · $704.00K · Q2 2026
- Kalehua Capital Management LLC 56.01K sh · $537.45K · Q3 2026
- ACT Capital Partners, L.P. 35.00K sh · $335.82K · Q3 2026
More on Bleichroeder LP
FAQ
How long has Bleichroeder LP held KZIA?
Bleichroeder LP has disclosed KZIA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Bleichroeder LP's current position in KZIA?
As of Q3 2026, Bleichroeder LP holds 490.41K shares of KZIA (KAZIA THERAPEUTICS), valued at $4.71M, representing 0.47% of its reported portfolio and ranking #46.
Has Bleichroeder LP been buying or selling KZIA?
In the latest 13F filing (Q3 2026), Bleichroeder LP increased its position in KZIA. The position peaked in Q2 2026 at 400.00K shares.
Which other funds hold KZIA?
Other major institutional holders of KZIA include Boxer Capital Management, LLC, Ikarian Capital, LLC, Dauntless Investment Group, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.